Some individuals with CACNA1A pathogenic variants may exhibit severe symptoms, including fatal refractory brain edema, stroke-like symptoms, recurrent loss of consciousness, coma, and visual impairment [6–8]. The gene discussed is CACNA1A; the disease is stroke disorder.